AssuredPartners Investment Advisors LLC Sells 5,214 Shares of UnitedHealth Group Incorporated $UNH

AssuredPartners Investment Advisors LLC lowered its position in UnitedHealth Group Incorporated (NYSE:UNH) by 80.6% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,256 shares of the healthcare conglomerate’s stock after selling 5,214 shares during the quarter. AssuredPartners Investment Advisors LLC’s holdings in UnitedHealth Group were worth $392,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of the company. Nabity Jensen Investment Management Inc lifted its position in shares of UnitedHealth Group by 0.9% during the 1st quarter. Nabity Jensen Investment Management Inc now owns 2,760 shares of the healthcare conglomerate’s stock worth $1,446,000 after buying an additional 24 shares during the period. Atlantic Edge Private Wealth Management LLC increased its stake in shares of UnitedHealth Group by 8.9% in the 1st quarter. Atlantic Edge Private Wealth Management LLC now owns 305 shares of the healthcare conglomerate’s stock valued at $160,000 after buying an additional 25 shares during the period. Osborne Partners Capital Management LLC increased its stake in shares of UnitedHealth Group by 2.5% in the 1st quarter. Osborne Partners Capital Management LLC now owns 1,066 shares of the healthcare conglomerate’s stock valued at $558,000 after buying an additional 26 shares during the period. HHM Wealth Advisors LLC increased its stake in shares of UnitedHealth Group by 0.9% in the 1st quarter. HHM Wealth Advisors LLC now owns 2,947 shares of the healthcare conglomerate’s stock valued at $1,544,000 after buying an additional 26 shares during the period. Finally, MPS Loria Financial Planners LLC grew its stake in shares of UnitedHealth Group by 0.4% during the first quarter. MPS Loria Financial Planners LLC now owns 7,256 shares of the healthcare conglomerate’s stock worth $3,800,000 after purchasing an additional 27 shares during the period. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $356.53 on Friday. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The company has a market capitalization of $322.90 billion, a price-to-earnings ratio of 15.45, a PEG ratio of 2.31 and a beta of 0.47. The stock’s 50 day moving average is $329.38 and its 200-day moving average is $344.86. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). The company had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company’s quarterly revenue was up 12.9% on a year-over-year basis. During the same quarter last year, the firm posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were paid a dividend of $2.21 per share. The ex-dividend date was Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.5%. UnitedHealth Group’s dividend payout ratio is presently 38.30%.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on UNH shares. UBS Group reiterated a “buy” rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Weiss Ratings restated a “sell (d+)” rating on shares of UnitedHealth Group in a report on Wednesday, October 8th. Morgan Stanley boosted their price target on UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a report on Friday, September 12th. Mizuho lifted their target price on UnitedHealth Group from $300.00 to $430.00 and gave the company an “outperform” rating in a research report on Thursday, October 9th. Finally, JPMorgan Chase & Co. lifted their target price on UnitedHealth Group from $310.00 to $425.00 and gave the company an “overweight” rating in a research report on Thursday, October 9th. Eighteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and four have assigned a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $385.13.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.